Abstract 12325: Feasibility and Efficacy of Morphine Therapy for Refractory Dyspnea as Palliative Care in End-stage Chronic Heart Failure Patients
Juri Kawaguchi(Kochi Medical School Hospital), Chisato Izumi(National Cerebral and Cardiovascular Center), Yasuko Takada(National Cerebral and Cardiovascular Center), Yasuhiro Hamatani(National Cerebral and Cardiovascular Center), Atsushi Hirayama(Nihon University), Hiroaki Kitaoka(Kōchi University), Emi Nakamura(Juntendo University), Yuta Anchi(National Cerebral and Cardiovascular Center), Kensuke Kuroda, Sayaka Funabashi(Kyorin University), Michiyo Azechi(National Cerebral and Cardiovascular Center), M Miyata(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Yukie Kawano(National Cerebral and Cardiovascular Center), Eri Nakai(National Cerebral and Cardiovascular Center)
Circulation
November 19, 2019
Cited by 0
Related Papers
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|353
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
|European Heart Journal|2018|323